CARLO DENNIS J PHD 5
5 · Adamis Pharmaceuticals Corp · Filed Feb 16, 2021
Insider Transaction Report
Form 5
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
- Exercise/Conversion
Common Stock
2020-02-21−27,823→ 316,405 total - Exercise/Conversion
Restricted Stock Units
2020-02-21−27,823→ 27,822 total→ Common Stock (27,823 underlying)
Holdings
- 150,709(indirect: By Trust)
Common Stock
- 5,883(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
- [F2]Includes common stock, as well as restricted stock units granted on January 30, 2019, to the reporting person and previously reported on a Form 4.
- [F3]On February 21, 2018, the reporting person was granted 83,467 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period